Long dedicated to the study of microbial pathogenesis and the treatment and prevention of infectious diseases, Ohio State established the Infectious Diseases Institute to further accelerate a collective capacity for solutions addressing the complexity of infectious diseases.
The institute is a direct outgrowth of a decade-long commitment and a multi- million-dollar investment in this area.
Infectious diseases are a leading cause of death worldwide and a major threat to our food supply and natural resources. Modern science has the potential to end this threat, but the challenge demands a strategic, efficient use of talent and resources and a global commitment to get it done. With its team-based approach, expertise in an unmatched range of disciplines including microbiology, and a comprehensive research agenda built around highly interconnected thematic programs, Ohio State’s Infectious Diseases Institute is meeting the infectious disease challenge.
The impact and scope of the institute's work is organized into six research areas, each of which focuses to eradicate infectious diseases in today’s global space. Two College of Pharmacy faculty members, Mark Mitton-Fry, assistant professor, and Karl Werbovetz, professor and chair of the Division of Medicinal Chemistry and Pharmacognosy, are co-directors of the Prevention, Detection and Therapies research area. Shaurya Prakash, a professor of Mechanical and Aerospace Engineering, is also a co-director of the research area.